Evidence map›Paper›PMID 36609372›Full record

ReviewJournal of neurosurgery. Pediatrics2023

Surveillance imaging and early surgical intervention for improved CNS tumor outcomes in children with Li-Fraumeni syndrome: Children's National Hospital experience and literature review.

Nirali Patel, Kathleen Felton, Surajit Bhattacharya, Maria Isabel Almira-Suarez, Augustine Eze, Joyce Turner, Robert Keating, Chima Oluigbo, Reuven J Schore, Lindsay Kilburn and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neurosurgery. Pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Nirali Patel1Division of Neurosurgery, Children's National Hospital, Washington, DC.
Kathleen Felton2Department of Pediatric Hematology/Oncology, University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada.
Surajit Bhattacharya3Center for Genetics Medicine Research, Children's National Hospital.
Maria Isabel Almira-Suarez4Division of Pathology, Children's National Hospital.
Augustine Eze3Center for Genetics Medicine Research, Children's National Hospital.
Joyce Turner5Division of Genetics and Metabolism, Children's National Hospital.
Robert Keating1Division of Neurosurgery, Children's National Hospital, Washington, DC.
Chima Oluigbo1Division of Neurosurgery, Children's National Hospital, Washington, DC.
Reuven J Schore6Division of Hematology/Oncology, Children's National Hospital.
Lindsay Kilburn6Division of Hematology/Oncology, Children's National Hospital.
Roger J Packer8Brain Tumor Institute, Children's National Hospital; and.
John S Myseros1Division of Neurosurgery, Children's National Hospital, Washington, DC.
Miriam Bornhorst3Center for Genetics Medicine Research, Children's National Hospital.
Children's National · USUniversity College London · GBNational Hospital · INGeorge Washington University · USJefferson Hospital for Neuroscience · USNational Hospital for Neurology and Neurosurgery · GBUniversity of Saskatchewan · CA

Funding

Neurobehavioral Evaluation CoreP50HD105328 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI LAUREN KENWORTHY · 2021 to 2026
$9.3M
Molecular Regulation of UreagenesisK01DK076846 · NIDDK · CHILDREN'S RESEARCH INSTITUTE · PI CALDOVIC, LJUBICA MORIZONO · 2008 to 2010
$323k
NICHD NIH HHS P50 HD105328NIDDK NIH HHS K01 DK076846
6 · The paper itself

Abstract

objectiveLi-Fraumeni syndrome (LFS) is a cancer predisposition syndrome caused by germline mutations in the TP53 gene. CNS tumors are the fourth most common tumor type in LFS, and recent screening guidelines demonstrate that early tumor detection is associated with improved long-term survival. However, there is a paucity of data regarding surgical intervention when lesions are identified in asymptomatic patients on surveillance imaging. The authors investigated this through their cohort and literature review.

methodsThe cohort consisted of children seen in the Pediatric Cancer Genetics Program at Children's National Hospital between August 2012 and August 2021. The authors also include a PubMed (MEDLINE) literature search of articles from 2006 to 2021 related to surveillance and CNS tumors in patients with LFS. Studies in which CNS tumors were not identified or detailed patient information was not provided were excluded. Patients from the selected articles and the authors' cohort were added for further analysis.

resultsBetween August 2012 and August 2021, 10 children with LFS and CNS tumors were assessed at Children's National Hospital: 4 who were known carriers of the TP53 mutation had CNS lesions found on surveillance imaging, whereas 6 presented with symptomatic CNS lesions and were either known or subsequently found to have germline TP53 mutations. The literature search identified 148 articles, 7 of which were included in this review. Patients from the literature and the present cohort were added for a total of 56 CNS lesions. A majority of the low-grade CNS lesions (22/24, 92%) were found on surveillance protocols in asymptomatic patients, whereas the majority of the high-grade lesions (22/26, 85%) presented in symptomatic patients who were not undergoing routine surveillance or as the initial diagnosis of LFS. The authors noted a significant survival advantage in pediatric patients with low-grade lesions, with an overall survival of 100% at 30 months. Minor limitations of the study include patient sample size and limitations in the patient cohort due to this being a retrospective rather than a prospective study.

conclusionsData presented in this study support surveillance protocols in LFS and demonstrate the importance of dedicated CNS imaging and early surgical intervention when lesions are identified. Systematic review registration no.: CRD42022372610 (www.crd.york.ac.uk/prospero).

Indexed as

Central Nervous System NeoplasmsLi-Fraumeni SyndromeChildGenes, p53Genetic Predisposition to DiseaseHospitalsHumansRetrospective StudiesTumor Suppressor Protein p53Tumor Suppressor Protein p53brain tumorLi-Fraumeni syndromeoncologyscreening

Identifiers

PMID36609372
PMCPMC11177722
OpenAlexW4313642968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.